Evidence mapPaperPMID 40979493Full record

ReviewJournal of inflammation research2025

The Crucial Roles of Platelets as Immune Mediators in Sepsis.

Xiaohui Yang, Jiasheng Song, Hui Ma, Ning Hua, Yanan Bai, Yuanzhi Ju, Jia-Wei Shen, Wei Zheng, Saiping Jiang

Abstract readReview
In one paragraph

Review in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Inhibition of IP6K1 suppresses NPA formation via platelet short-chain polyphosphate polymers in necrotizing enterocolitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaohui YangSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China.
Jiasheng SongSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China.
Hui MaDepartment of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, People's Republic of China.
Ning HuaDepartment of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, People's Republic of China.
Yanan BaiDepartment of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, People's Republic of China.
Yuanzhi JuDepartment of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, People's Republic of China.
Jia-Wei ShenSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China.
Wei ZhengSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China.
Saiping JiangSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a life-threatening disease characterized by organ dysfunction resulting from a dysregulated host response to infection, potentially progressing to septic shock. Decreased platelet count and platelet dysfunction serve as crucial clinical markers for assessing the severity and prognosis of sepsis. Historically, platelets have been recognized primarily for their role in hemostasis and thrombosis. However, researches have increasingly demonstrated their significant involvement in innate immunity, contributing to the inflammatory response and coagulation dysfunction in sepsis, mediating sepsis-related complications. The mitigation of the inflammatory response and the suppression of immune mediator release can be achieved through the inhibition of platelet activation, thereby underscoring the therapeutic potential of antiplatelet therapy in ameliorating sepsis. This paper systematically discusses the role of platelets in sepsis, from pathological mechanisms to therapeutic targets, integrating cutting-edge research advances and clinical practice needs to provide a theoretical foundation and translational direction for precision treatment of sepsis.

Indexed as

antiplatelet therapycoagulationinflammatoryplateletssepsis

Identifiers

PMID40979493
PMCPMC12449891

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.